Letter: Diffuse Isocitrate Dehydrogenase-Mutant Gliomas With Histone H3 Alterations are Distinguished by Unique Clinical Characteristics, Molecular Expression Profile, and Survival Prognosis.
Sabrina RahmanRobert Ahmed KhanMuhtamim ChowdhuryMahbub HasanMd Raziul HaqueMd Moshiur RahmanPublished in: Neurosurgery (2024)